These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20969774)

  • 1. CyberKnife for hilar lung tumors: report of clinical response and toxicity.
    Unger K; Ju A; Oermann E; Suy S; Yu X; Vahdat S; Subramaniam D; Harter KW; Collins SP; Dritschilo A; Anderson E; Collins BT
    J Hematol Oncol; 2010 Oct; 3():39. PubMed ID: 20969774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment.
    Vahdat S; Oermann EK; Collins SP; Yu X; Abedalthagafi M; Debrito P; Suy S; Yousefi S; Gutierrez CJ; Chang T; Banovac F; Anderson ED; Esposito G; Collins BT
    J Hematol Oncol; 2010 Feb; 3():6. PubMed ID: 20132557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer.
    Collins BT; Vahdat S; Erickson K; Collins SP; Suy S; Yu X; Zhang Y; Subramaniam D; Reichner CA; Sarikaya I; Esposito G; Yousefi S; Jamis-Dow C; Banovac F; Anderson ED
    J Hematol Oncol; 2009 Jan; 2():1. PubMed ID: 19149899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic ablative body radiotherapy with a central high dose using CyberKnife for metastatic lung tumors.
    Hayashi K; Suzuki O; Shiomi H; Ono H; Setoguchi A; Nakai M; Nakanishi E; Tatekawa S; Ose N; Hirata T; Tamari K; Seo Y; Funaki S; Isohashi F; Shimizu S; Shintani Y; Ogawa K
    BMC Cancer; 2023 Mar; 23(1):215. PubMed ID: 36882702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CyberKnife radiosurgery for stage I lung cancer: results at 36 months.
    Brown WT; Wu X; Fayad F; Fowler JF; Amendola BE; García S; Han H; de la Zerda A; Bossart E; Huang Z; Schwade JG
    Clin Lung Cancer; 2007 Sep; 8(8):488-92. PubMed ID: 17922973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body metastases: acceptable local control and normal tissue tolerance with 5 fraction approach.
    Gill B; Oermann E; Ju A; Suy S; Yu X; Rabin J; Kalhorn C; Nair MN; Voyadzis JM; Unger K; Collins SP; Harter KW; Collins BT
    Front Oncol; 2012; 2():39. PubMed ID: 22645718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose hilar and mediastinal stereotactic body radiation therapy for non-small cell lung cancer: Analysis of outcomes in patients receiving one or multiple courses of treatment.
    Kowalchuk RO; Waters MR; Richardson M; Spencer K; Larner JM; Kersh CR
    Thorac Cancer; 2020 Jul; 11(7):2005-2013. PubMed ID: 32469465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy.
    Kelley KD; Benninghoff DL; Stein JS; Li JZ; Byrnes RT; Potters L; Knisely JP; Zinkin HD
    Radiat Oncol; 2015 May; 10():120. PubMed ID: 26018408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CyberKnife with Tumor Tracking: An Effective Treatment for High-Risk Surgical Patients with Stage I Non-Small Cell Lung Cancer.
    Chen VJ; Oermann E; Vahdat S; Rabin J; Suy S; Yu X; Collins SP; Subramaniam D; Banovac F; Anderson E; Collins BT
    Front Oncol; 2012; 2():9. PubMed ID: 22655258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors.
    Le QT; Loo BW; Ho A; Cotrutz C; Koong AC; Wakelee H; Kee ST; Constantinescu D; Whyte RI; Donington J
    J Thorac Oncol; 2006 Oct; 1(8):802-9. PubMed ID: 17409963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breathing-motion-compensated robotic guided stereotactic body radiation therapy : Patterns of failure analysis.
    Stera S; Balermpas P; Chan MKH; Huttenlocher S; Wurster S; Keller C; Imhoff D; Rades D; Dunst J; Rödel C; Hildebrandt G; Blanck O
    Strahlenther Onkol; 2018 Feb; 194(2):143-155. PubMed ID: 28875297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic body radiotherapy for central lung tumors.
    Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
    J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung metastases treated by CyberKnife image-guided robotic stereotactic radiosurgery at 41 months.
    Brown WT; Wu X; Fowler JF; García S; Fayad F; Amendola BE; de la Zerda A; Schwade JG
    South Med J; 2008 Apr; 101(4):376-82. PubMed ID: 18360342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicities of organs at risk in the mediastinal and hilar regions following stereotactic body radiotherapy for centrally located lung tumors.
    Nishimura S; Takeda A; Sanuki N; Ishikura S; Oku Y; Aoki Y; Kunieda E; Shigematsu N
    J Thorac Oncol; 2014 Sep; 9(9):1370-6. PubMed ID: 25122433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-fraction stereotactic radiosurgery (SRS) for single inoperable high-risk non-small cell lung cancer (NSCLC) brain metastases.
    Lischalk JW; Oermann E; Collins SP; Nair MN; Nayar VV; Bhasin R; Voyadzis JM; Rudra S; Unger K; Collins BT
    Radiat Oncol; 2015 Oct; 10():216. PubMed ID: 26503609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors.
    Trakul N; Chang CN; Harris J; Chapman C; Rao A; Shen J; Quinlan-Davidson S; Filion EJ; Wakelee HA; Colevas AD; Whyte RI; Dieterich S; Maxim PG; Hristov D; Tran P; Le QT; Loo BW; Diehn M
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):231-7. PubMed ID: 22381907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiation therapy of lung tumors: preliminary experience using normal tissue complication probability-based dose limits.
    Song DY; Benedict SH; Cardinale RM; Chung TD; Chang MG; Schmidt-Ullrich RK
    Am J Clin Oncol; 2005 Dec; 28(6):591-6. PubMed ID: 16317270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary effect of Cyberknife radiosurgery in the treatment of 31 patients with advanced non-small cell lung cancer].
    Lv Y; Wang Z; Zhu X; Shen Z; Yuan D; Miao X; Shi Y; Song Y
    Zhongguo Fei Ai Za Zhi; 2011 Apr; 14(4):329-34. PubMed ID: 21496431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases.
    Lischalk JW; Malik RM; Collins SP; Collins BT; Matus IA; Anderson ED
    Radiat Oncol; 2016 Feb; 11():28. PubMed ID: 26920142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer.
    Temming S; Kocher M; Stoelben E; Hagmeyer L; Chang DH; Frank K; Hekmat K; Wolf J; Baus WW; Semrau R; Baues C; Marnitz S
    Strahlenther Onkol; 2018 Feb; 194(2):91-97. PubMed ID: 28812120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.